Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Neurizon Therapeutics Appoints Dr Chris Bremer As Chief Executive Officer

PRIVATESep 07, 2026•about 24 hours ago

Position

Chief Executive Officer

Company

Neurizon Therapeutics

Dr Chris Bremer
MelbourneBiotechnologyHealth CareTherapeutics

Description

Neurizon Therapeutics has named Dr Chris Bremer as its new CEO, bringing extensive pharmaceutical leadership experience. Bremer will oversee the company's operations during a critical phase of its drug trials for ALS.

Company Information

Company

Neurizon Therapeutics

Location

Melbourne, Victoria, Australia

About

Neurizon Therapeutics is a clinical-stage company focused on developing innovative treatments. The company aims to advance the commercialization of its lead drug candidate, NUZ-001. It has a strategy to transition to in-house financial operations to optimize its finance functions.

Don't miss Neurizon Therapeutics's next move

Get an email the moment Neurizon Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Dan
Likely contact at this company
••••••••@••••••••

See Dan's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Neurizon Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Neurizon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.